Allovir Company Insiders

ALVR Stock  USD 0.55  0.01  1.85%   
Allovir's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Allovir suggests that virtually all insiders are panicking. Allovir employs about 8 people. The company is managed by 12 executives with a total tenure of roughly 19 years, averaging almost 1.0 years of service per executive, having 0.67 employees per reported executive.

Allovir's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-11-19Diana BrainardDisposed 8706 @ 0.55View
2024-10-21Vikas SinhaDisposed 1546 @ 0.78View
2024-10-03Diana BrainardDisposed 1493 @ 0.81View
2024-08-05Diana BrainardDisposed 10847 @ 0.73View
2024-07-22Brett R HagenDisposed 481 @ 0.74View
2024-07-19Vikas SinhaDisposed 1542 @ 0.75View
Monitoring Allovir's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allovir. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Allovir Stock, please use our How to Invest in Allovir guide.

Allovir Management Team Effectiveness

The company has return on total asset (ROA) of (0.3653) % which means that it has lost $0.3653 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8033) %, meaning that it created substantial loss on money invested by shareholders. Allovir's management efficiency ratios could be used to measure how well Allovir manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/30/2024, Return On Tangible Assets is likely to grow to -0.95. In addition to that, Return On Capital Employed is likely to drop to -1.17. At this time, Allovir's Total Assets are relatively stable compared to the past year. As of 11/30/2024, Other Current Assets is likely to grow to about 5.1 M, while Non Current Assets Total are likely to drop slightly above 3 M.
As of 11/30/2024, Common Stock Shares Outstanding is likely to drop to about 68.3 M. In addition to that, Net Loss is likely to grow to about (144.2 M)

Allovir Workforce Comparison

Allovir is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 2,265. Allovir adds roughly 8.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Allovir Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Allovir insiders, such as employees or executives, is commonly permitted as long as it does not rely on Allovir's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Allovir insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Allovir Notable Stakeholders

An Allovir stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Allovir often face trade-offs trying to please all of them. Allovir's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Allovir's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Sonia ChoiSenior RelationsProfile
Agustin MDAdvisorProfile
Dana MBAVP OperationsProfile
Ann LeenChief OfficerProfile
Cintia PharmDChief OfficerProfile
David HallalExecutive BoardProfile
Jeroen BeekConsultantProfile
Diana MDCEO DirectorProfile
Ugo PerlingieriHead OperationsProfile
Brett HagenChief OfficerProfile
Edward JDGeneral SecretaryProfile
Dana AlexanderSenior OperationsProfile

About Allovir Management Performance

The success or failure of an entity such as Allovir often depends on how effective the management is. Allovir management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Allovir management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Allovir management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.00)(0.95)
Return On Capital Employed(1.12)(1.17)
Return On Assets(1.00)(0.95)
Return On Equity(1.31)(1.24)

Allovir Workforce Analysis

Traditionally, organizations such as Allovir use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Allovir within its industry.

Allovir Manpower Efficiency

Return on Allovir Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee23.8M
Net Loss Per Executive15.9M
Working Capital Per Employee19.9M
Working Capital Per Executive13.3M

Additional Tools for Allovir Stock Analysis

When running Allovir's price analysis, check to measure Allovir's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allovir is operating at the current time. Most of Allovir's value examination focuses on studying past and present price action to predict the probability of Allovir's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allovir's price. Additionally, you may evaluate how the addition of Allovir to your portfolios can decrease your overall portfolio volatility.